Using the B16 melanoma model (Fig. 6b), we found that FcγRIIB+ CD8+ also express significantly more Fgl2 at the protein level than FcγRIIB− CD8+ T cells (Fig. 6c–e). The gene discussed is FCGR2B; the disease is melanoma.